Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Engineering Immune Organoids to Study Pediatric Cancer (IMMUNE-ORGANOIDS)

NCT05890781 is registered in ClinicalTrials.gov with Gustave Roussy, Cancer Campus, Grand Paris as lead sponsor.

NCT NCT05890781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05890781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Engineering Immune Organoids to Study Pediatric Cancer (IMMUNE-ORGANOIDS)
Lead sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Phase
Not applicable
Overall status
Recruiting
Start date
May 12, 2023
Completion date
May 31, 2028
Enrollment
108 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, kidney tumor, neuroblastoma, sarcoma